CIK 0001736243 · <br>Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- S-1 Offering Registration Statement
- 8-K Event Delisting notice
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale · Other events
- 424B5 Offering Prospectus
- 8-K Event Delisting notice
- EFFECT Other Notice of Effectiveness
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy Director bought 24,631 shares at $1.02 ($25,000)
Page 5 of 13 · 246 filings